Uwe Schlokat
Chief Executive Officer at Sentinext Therapeutics Sdn. Bhd.
Profile
Uwe Schlokat is currently the Chief Executive Officer & Executive Director at Sentinext Therapeutics Sdn.
Bhd., Chairman-Supervisory Board at Zytoprotec GmbH, and Non-Executive Director at PrIME Biologics Pte Ltd.
Previously, he worked as a Director at Functional Enviromics Technologies SA, Principal at Genentech, Inc., and Head-Product Development at Immuno AG.
Dr. Schlokat holds a graduate and doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Uwe Schlokat active positions
| Companies | Position | Start |
|---|---|---|
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Chairman | - |
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Director/Board Member | - |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Chief Executive Officer | - |
Former positions of Uwe Schlokat
| Companies | Position | End |
|---|---|---|
| Immuno AG | Corporate Officer/Principal | - |
Functional Enviromics Technologies SA
 Functional Enviromics Technologies SA BiotechnologyHealth Technology Functional Enviromics Technologies SA provides biotechnology solutions. It develops chemically defined cell culture media for life sciences research institutions and industries. The firm offers cell functional enviromics (CFE) sciences and derived technologies. Its CFE technology engineers cellular metabolism which enables increased cell culture performance and decreases development time for media formulation. The company was founded by Rui Oliveira, Inês Isidro, João Dias, Nuno Carinhas, Filipe Ataíde, and Ana Ferreira in 2013 and is headquartered in Caparica, Portugal. | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Uwe Schlokat
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Immuno AG | |
Zytoprotec GmbH
Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Health Technology |
Functional Enviromics Technologies SA
Functional Enviromics Technologies SA BiotechnologyHealth Technology Functional Enviromics Technologies SA provides biotechnology solutions. It develops chemically defined cell culture media for life sciences research institutions and industries. The firm offers cell functional enviromics (CFE) sciences and derived technologies. Its CFE technology engineers cellular metabolism which enables increased cell culture performance and decreases development time for media formulation. The company was founded by Rui Oliveira, Inês Isidro, João Dias, Nuno Carinhas, Filipe Ataíde, and Ana Ferreira in 2013 and is headquartered in Caparica, Portugal. | Health Technology |
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Stock Market
- Insiders
- Uwe Schlokat
